Albireo Pharma Inc (NQ: ALBO )
34.86
USD
-0.22
(-0.63%)
Streaming Delayed Price
Updated: 4:04 PM EST, Feb 26, 2021
Add to My Watchlist
Press releases about Albireo Pharma Inc
Albireo to Report Q4 and Year-End 2020 Financial Results on February 25
February 18, 2021
Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 17, 2021
Albireo Presents Odevixibat Commercialization Road to $1 Billion
February 11, 2021
Albireo to Host Virtual Investor Commercial Day 2021
January 07, 2021
Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 11, 2020
Albireo Reports Q3 2020 Financial Results and Provides Business Update
November 05, 2020
Albireo Announces Presentations at NASPGHAN 2020 Annual Meeting
October 23, 2020
Albireo Recognizes PFIC Awareness Day 2020
October 05, 2020
Albireo Prices Public Offering of 4,000,000 Shares of Common Stock
September 09, 2020
Albireo Phase 3 Trial Meets Both Primary Endpoints for Odevixibat in PFIC
September 08, 2020
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.